213 related articles for article (PubMed ID: 10910037)
21. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
22. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
23. Loss of beta-catenin expression in metastatic gastric cancer.
Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
[TBL] [Abstract][Full Text] [Related]
24. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
Wakita K; Tetsu O; McCormick F
Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
[TBL] [Abstract][Full Text] [Related]
25. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
[TBL] [Abstract][Full Text] [Related]
26. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
27. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
28. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
Michaelson JS; Leder P
Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
[TBL] [Abstract][Full Text] [Related]
29. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C
Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100
[TBL] [Abstract][Full Text] [Related]
30. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
31. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
Mirabelli-Primdahl L; Gryfe R; Kim H; Millar A; Luceri C; Dale D; Holowaty E; Bapat B; Gallinger S; Redston M
Cancer Res; 1999 Jul; 59(14):3346-51. PubMed ID: 10416591
[TBL] [Abstract][Full Text] [Related]
32. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
33. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
34. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
35. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
36. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
[TBL] [Abstract][Full Text] [Related]
37. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
38. beta-catenin signaling and cancer.
Morin PJ
Bioessays; 1999 Dec; 21(12):1021-30. PubMed ID: 10580987
[TBL] [Abstract][Full Text] [Related]
39. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors.
Takahashi M; Fukuda K; Sugimura T; Wakabayashi K
Cancer Res; 1998 Jan; 58(1):42-6. PubMed ID: 9426055
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]